Afficher la notice abrégée
dc.creator | Manns, M. | en |
dc.creator | Jeffers, L. | en |
dc.creator | Dalekos, G. | en |
dc.creator | Berg, T. | en |
dc.creator | Trepo, C. | en |
dc.creator | Roberts, S. | en |
dc.creator | Prieto, M. | en |
dc.creator | Rizzetto, M. | en |
dc.creator | Sorbel, J. | en |
dc.creator | Anderson, J. | en |
dc.creator | Mondou, E. | en |
dc.creator | Rousseau, F. | en |
dc.date.accessioned | 2015-11-23T10:38:42Z | |
dc.date.available | 2015-11-23T10:38:42Z | |
dc.date.issued | 2008 | |
dc.identifier | 10.1016/s0168-8278(08)60076-8 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.uri | http://hdl.handle.net/11615/30632 | |
dc.source.uri | <Go to ISI>://WOS:000256683200075 | |
dc.subject | Gastroenterology & Hepatology | en |
dc.title | The antiviral response to tenofovir disoproxil fumarate (TDF) is comparable in lamivudine (LAM)-naive and LAM-experienced subjects treated for chronic hepatitis B (CHB) | en |
dc.type | journalArticle | en |
Fichier(s) constituant ce document
Il n'y a pas de fichiers associés à ce document.
|
Ce document figure dans la(les) collection(s) suivante(s)
Afficher la notice abrégée